| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MDRX | Common Stock | Sale | $208,284 | -10,000 | -1.8% | $20.83 | 531,593 | 15 Feb 2022 | Direct | F1, F2 |
| transaction | MDRX | Common Stock | Sale | $207,353 | -10,000 | -1.9% | $20.74 | 521,593 | 16 Feb 2022 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | The sale of shares reported in the Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021. |
| F2 | These transactions were executed in multiple trades at prices ranging from $20.676 to $20.95. The prices reported reflect the weighted average sale price on the transaction date. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. |
| F3 | These transactions were executed in multiple trades at prices ranging from $20.56 to $20.855. The prices reported reflect the weighted average sale price on the transaction date. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. |